-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Inhibikase Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q3 2024.
- Inhibikase Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -2.01B %, a 32475675% decline year-over-year.
- Inhibikase Therapeutics, Inc. annual Operating Margin for 2023 was -7.71K %, a 47.5% increase from 2022.
- Inhibikase Therapeutics, Inc. annual Operating Margin for 2022 was -14.7K %, a 2984% decline from 2021.
- Inhibikase Therapeutics, Inc. annual Operating Margin for 2021 was -476 %, a 18% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)